
      



  
    


      
    Guidance
  

  
  
    In vitro diagnostic point-of-care test devices
  

  
  

  
    
  Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.

  



  
    
      
  
      From:
      
          Medicines and Healthcare products Regulatory Agency

      
      Published
      22 July 2005
      Last updated
      
        3 February 2021
          — 
            See all updates
          
      
  

    
    
    
  










  
    
      

      
          
    Documents


      

    
        
  
      
  
  
    In vitro diagnostic point-of-care test devices
    
        PDF, 221KB, 22 pages
    


      
        This file may not be suitable for users of assistive technology.
        
  
    
      Request an accessible format.
    
  
  
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email webupdates@mhra.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  
      
  

  
      
  
  
    Management and use of IVD point of care test devices 
    
        HTML
    


  



  


        
          Details


          

    
            
This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance is for people involved in the management and use of POCT services in primary and secondary care including:


  managerial staff
  scientific staff
  technical
  clinical and nursing staff


While many of the issues are relevant to the performance of POCT in a hospital environment, the principles also apply to their use in:


  outpatient clinics
  community care
  GP practices
  community providers
  primary care settings




        
      

      
    Published 22 July 2005
    Last updated 3 February 2021
      + show all updates
      
        
            
              3 February 2021
              Published a new version of the guidance following the end of the transition period. The guidance has now also been published in HTML format.
            
            
              22 July 2005
              First published.
            
        
      



      
    
  
  

  


    
  

      
        Related content
      




      


  


        In vitro diagnostic medical devices: procurement, safety, quality and performance
        In vitro diagnostic (IVD) devices: use, safety and management
        In-house manufacture of medical devices in Great Britain
        Approved bodies for medical devices
        Custom-made medical devices in Great Britain

  




      

    Collection

  


        In vitro diagnostic (IVD) devices: use, safety and management
        Medical devices: safety guidance
        Medicines and medical devices: product-specific information

  


  



    


  Brexit
  
    Check what you need to do









  
    
        
  
    
  





      

    Explore the topic

  


        Medical devices regulation and safety

  


  

  


    
  


    